These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
241 related articles for article (PubMed ID: 25873958)
1. Soluble α -Klotho Serum Levels in Chronic Kidney Disease. Rotondi S; Pasquali M; Tartaglione L; Muci ML; Mandanici G; Leonangeli C; Sales S; Farcomeni A; Mazzaferro S Int J Endocrinol; 2015; 2015():872193. PubMed ID: 25873958 [TBL] [Abstract][Full Text] [Related]
2. Serum levels of soluble secreted α-Klotho are decreased in the early stages of chronic kidney disease, making it a probable novel biomarker for early diagnosis. Shimamura Y; Hamada K; Inoue K; Ogata K; Ishihara M; Kagawa T; Inoue M; Fujimoto S; Ikebe M; Yuasa K; Yamanaka S; Sugiura T; Terada Y Clin Exp Nephrol; 2012 Oct; 16(5):722-9. PubMed ID: 22457086 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease. Wan M; Smith C; Shah V; Gullet A; Wells D; Rees L; Shroff R Nephrol Dial Transplant; 2013 Jan; 28(1):153-61. PubMed ID: 23180879 [TBL] [Abstract][Full Text] [Related]
4. Secreted Klotho and FGF23 in chronic kidney disease Stage 1 to 5: a sequence suggested from a cross-sectional study. Pavik I; Jaeger P; Ebner L; Wagner CA; Petzold K; Spichtig D; Poster D; Wüthrich RP; Russmann S; Serra AL Nephrol Dial Transplant; 2013 Feb; 28(2):352-9. PubMed ID: 23129826 [TBL] [Abstract][Full Text] [Related]
5. The relationship between urinary kidney injury molecule-1 and blood bone metabolism markers in patients with chronic kidney disease . Yin C; Cheng C; Wang J; Zhang L; Purrunsing Y; Yang G; Zeng M; Huang H; Ren W; Ye Y; Ma H; Xing C; Wang N Clin Nephrol; 2020 Feb; 93(2):65-76. PubMed ID: 31793871 [TBL] [Abstract][Full Text] [Related]
6. Intact FGF23 and α-Klotho during acute inflammation/sepsis in CKD patients. Dounousi E; Torino C; Pizzini P; Cutrupi S; Panuccio V; D'Arrigo G; Abd ElHafeez S; Tripepi G; Mallamaci F; Zoccali C Eur J Clin Invest; 2016 Mar; 46(3):234-41. PubMed ID: 26728476 [TBL] [Abstract][Full Text] [Related]
7. Association between FGF23, α-Klotho, and Cardiac Abnormalities among Patients with Various Chronic Kidney Disease Stages. Tanaka S; Fujita S; Kizawa S; Morita H; Ishizaka N PLoS One; 2016; 11(7):e0156860. PubMed ID: 27400031 [TBL] [Abstract][Full Text] [Related]
8. [Effect of Ronghuang Granule on serum FGF23, FGFRs and Klotho in non-dialysis patients with CKD-MBD and kidney deficiency and damp-heat syndrome]. Hu S; Wang D; Zhang R; Cao Y; Jin H; Mao Y; Wei L; Ren K; Zhang X; Wang Y Nan Fang Yi Ke Da Xue Xue Bao; 2018 Dec; 38(12):1427-1432. PubMed ID: 30613009 [TBL] [Abstract][Full Text] [Related]
9. Parathyroid function in chronic kidney disease: role of FGF23-Klotho axis. Koizumi M; Komaba H; Fukagawa M Contrib Nephrol; 2013; 180():110-23. PubMed ID: 23652554 [TBL] [Abstract][Full Text] [Related]
10. The FGF23-Klotho axis and cardiac tissue Doppler imaging in pediatric chronic kidney disease-a prospective cohort study. Tranæus Lindblad Y; Olauson H; Vavilis G; Hammar U; Herthelius M; Axelsson J; Bárány P Pediatr Nephrol; 2018 Jan; 33(1):147-157. PubMed ID: 28795324 [TBL] [Abstract][Full Text] [Related]
11. Serum klotho: relation to fibroblast growth factor-23 and other regulators of phosphate metabolism in children with chronic kidney disease. Sawires HK; Essam RM; Morgan MF; Mahmoud RA Nephron; 2015; 129(4):293-9. PubMed ID: 25766835 [TBL] [Abstract][Full Text] [Related]
12. Fucoidan Ameliorates Renal Injury-Related Calcium-Phosphorus Metabolic Disorder and Bone Abnormality in the CKD-MBD Model Rats by Targeting FGF23-Klotho Signaling Axis. Liu BH; Chong FL; Yuan CC; Liu YL; Yang HM; Wang WW; Fang QJ; Wu W; Wang MZ; Tu Y; Wan ZY; Wan YG; Wu GW Front Pharmacol; 2020; 11():586725. PubMed ID: 33708111 [No Abstract] [Full Text] [Related]
13. Relationship between cFGF23/Klotho ratio and phosphate levels in patients with chronic kidney disease. Liu Z; Zhou H; Chen X; Chen H; Wang Y; Wang T; Cai L; Hong Y; Ke H; Zheng J Int Urol Nephrol; 2019 Mar; 51(3):503-507. PubMed ID: 30689182 [TBL] [Abstract][Full Text] [Related]
14. [Role of parathyroid hormone in Klotho-FGF23 system]. Kimura T; Shiizaki K; Kuro-O M Clin Calcium; 2016 Jun; 26(6):859-66. PubMed ID: 27230841 [TBL] [Abstract][Full Text] [Related]
15. A decreased soluble Klotho level with normal eGFR, FGF23, serum phosphate, and FEP in an ADPKD patient with enlarged kidneys due to multiple cysts. Kanai T; Shiizaki K; Betsui H; Aoyagi J; Yamagata T CEN Case Rep; 2018 Nov; 7(2):259-263. PubMed ID: 29767399 [TBL] [Abstract][Full Text] [Related]
16. Longitudinal FGF23 and Klotho axis characterization in children treated with chronic peritoneal dialysis. Cano FJ; Freundlich M; Ceballos ML; Rojo AP; Azocar MA; Delgado IO; Ibacache MJ; Delucchi MA; Lillo AM; Irarrázabal CE; Ugarte MF Clin Kidney J; 2014 Oct; 7(5):457-63. PubMed ID: 25878777 [TBL] [Abstract][Full Text] [Related]
18. [Correlations of FGF23 and Klotho with cardiovascular injury in chronic kidney disease patients]. Gan L; Zhou Q Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Sep; 42(9):1058-1065. PubMed ID: 28989152 [TBL] [Abstract][Full Text] [Related]
19. Correlation between Soluble Wang Q; Su W; Shen Z; Wang R Biomed Res Int; 2018; 2018():9481475. PubMed ID: 30159331 [TBL] [Abstract][Full Text] [Related]
20. [CKD-MBD (Chronic Kidney Disease-Mineral and Bone Disorder). Role of FGF23-Klotho axis in CKD-MBD]. Komaba H Clin Calcium; 2010 Jul; 20(7):1028-36. PubMed ID: 20585181 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]